Background/Aims: Suicidal behavior (SB) in bipolar disorder (BD) is a complex multifactorial event resulting from an interaction of genetic, neurobiological and psychosocial factors. Recent studies identified new possible mechanisms, suggesting a role for sirtuins (SIRTs 1-7), a family of nicotinamide adenine dinucleotide-dependent enzymes with a multifaceted role in the central nervous system. The aims of the present study were: (1) to investigate the effects of the rs10997870 SIRT1 gene variant on SB in BD; (2) to explore the effects of the same gene variant on specific depressive symptoms at the severest episode. Methods: One hundred and eighty DSM-IV bipolar outpatients were enrolled in a naturalistic cohort study. The rs10997870 polymorphism within the SIRT1 gene was analyzed. Results: An association between the GG genotype and SB was detected (lifetime: p = 0.015). Compared to other genotypes, GG carriers presented more frequently psychomotor agitation (p = 0.009) and a higher Hamilton Depression Rating Scale total score (p = 0.014) at the severest depressive episode. SB and psychomotor agitation were found to be associated with GG carriers and G allele in a multivariate analysis as well. Conclusion: Our findings suggest a role of the rs10997870 SIRT1 gene variant in SB amongst BD patients and its association with specific depressive symptoms. Despite a number of limitations of this exploratory study, our results may provide new insight into the mechanisms underlying SB in BD.

Keywords:
Bipolar disorder, Suicidal behavior, SIRT1 gene variant, rs10997870 polymorphism
1.
Angst J, Angst F, Gerber-Werder R, Gamma A: Suicide in 406 mood-disorder patients with and without long-term medication: a 40 to 44 years' follow-up. Arch Suicide Res 2005;9:279-300.
2.
Baldessarini RJ, Pompili M, Tondo L: Suicide in bipolar disorder: risks and management. CNS Spectr 2006;11:465-471.
3.
Bondy B, Buettner A, Zill P: Genetics of suicide. Mol Psychiatry 2006;11:336-351.
4.
Grande IBM, Birmaher B, Vieta E: Bipolar disorder. Lancet, in press.
5.
Nock MK, Borges G, Bromet EJ, Cha CB, Kessler RC, Lee S: Suicide and suicidal behavior. Epidemiol Rev 2008;30:133-154.
6.
Wasserman D, Geijer T, Sokolowski M, Rozanov V, Wasserman J: Nature and nurture in suicidal behavior, the role of genetics: some novel findings concerning personality traits and neural conduction. Physiol Behav 2007;92:245-249.
7.
Calati R, Porcelli S, Giegling I, Hartmann AM, Moller HJ, De Ronchi D, et al: Catechol-o-methyltransferase gene modulation on suicidal behavior and personality traits: review, meta-analysis and association study. J Psychiatr Res 2011;45:309-321.
8.
Brezo J, Klempan T, Turecki G: The genetics of suicide: a critical review of molecular studies. Psychiatr Clin North Am 2008;31:179-203.
9.
Jimenez E, Arias B, Mitjans M, Goikolea JM, Roda E, Saiz PA, et al: Genetic variability at IMPA2, INPP1 and GSK3beta increases the risk of suicidal behavior in bipolar patients. Eur Neuropsychopharmacol 2013;23:1452-1462.
10.
Giegling I, Chiesa A, Mandelli L, Gibiino S, Hartmann AM, Moller HJ, et al: Influence of neuronal cell adhesion molecule (NCAM1) variants on suicidal behaviour and correlated traits. Psychiatry Res 2010;179:222-225.
11.
Abe N, Uchida S, Otsuki K, Hobara T, Yamagata H, Higuchi F, et al: Altered sirtuin deacetylase gene expression in patients with a mood disorder. J Psychiatr Res 2011;45:1106-1112.
12.
Akbarian S: Approaching the molecular pathology of suicide. Biol Psychiatry 2008;64:643-644.
13.
Bredy TW, Sun YE, Kobor MS: How the epigenome contributes to the development of psychiatric disorders. Dev Psychobiol 2010;52:331-342.
14.
Uchida S, Hara K, Kobayashi A, Otsuki K, Yamagata H, Hobara T, et al: Epigenetic status of GDNF in the ventral striatum determines susceptibility and adaptation to daily stressful events. Neuron 2011;69:359-372.
15.
Bao J, Sack MN: Protein deacetylation by sirtuins: delineating a post-translational regulatory program responsive to nutrient and redox stressors. Cell Mol Life Sci 2010;67:3073-3087.
16.
Chung S, Yao H, Caito S, Hwang JW, Arunachalam G, Rahman I: Regulation of SIRT1 in cellular functions: role of polyphenols. Arch Biochem Biophys 2010;501:79-90.
17.
Albani D, Polito L, Signorini A, Forloni G: Neuroprotective properties of resveratrol in different neurodegenerative disorders. Biofactors 2010;36:370-376.
18.
Porcelli S, Salfi R, Politis A, Atti AR, Albani D, Chierchia A, et al: Association between sirtuin 2 gene rs10410544 polymorphism and depression in Alzheimer's disease in two independent European samples. J Neural Transm 2013;120:1709-1715.
19.
Alcendor RR, Gao S, Zhai P, Zablocki D, Holle E, Yu X, et al: SIRT1 regulates aging and resistance to oxidative stress in the heart. Circ Res 2007;100:1512-1521.
20.
Gao J, Wang WY, Mao YW, Graff J, Guan JS, Pan L, et al: A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature 2010;466:1105-1109.
21.
Lee JY, Ahn K, Jang BG, Park SH, Kang HJ, Heo JI, et al: Nicotinamide reduces dopamine in postnatal hypothalamus and causes dopamine-deficient phenotype. Neurosci Lett 2009;461:163-166.
22.
Kishi T, Yoshimura R, Kitajima T, Okochi T, Okumura T, Tsunoka T, et al: SIRT1 gene is associated with major depressive disorder in the Japanese population. J Affect Disord 2010;126:167-173.
23.
Michan S, Li Y, Chou MM, Parrella E, Ge H, Long JM, et al: SIRT1 is essential for normal cognitive function and synaptic plasticity. J Neurosci 2010;30:9695-9707.
24.
Libert S, Pointer K, Bell EL, Das A, Cohen DE, Asara JM, et al: SIRT1 activates MAO-A in the brain to mediate anxiety and exploratory drive. Cell 2011;147:1459-1472.
25.
Webb RT, Lichtenstein P, Larsson H, Geddes JR, Fazel S: Suicide, hospital-presenting suicide attempts, and criminality in bipolar disorder: examination of risk for multiple adverse outcomes. J Clin Psychiatry 2014;75:e809-e816.
26.
Costa L da S, Alencar AP, Nascimento Neto PJ, dos Santos M do S, da Silva CG, Pinheiro S de F, et al: Risk factors for suicide in bipolar disorder: a systematic review. J Affect Disord 2015;170:237-254.
27.
Zai CC, Manchia M, Sonderby IE, Yilmaz Z, De Luca V, Tiwari AK, et al: Investigation of the genetic interaction between BDNF and DRD3 genes in suicidical behaviour in psychiatric disorders. World J Biol Psychiatry 2015;16:171-179.
28.
Baek JH, Heo JY, Fava M, Mischoulon D, Nierenberg A, Hong JP, et al: Anxiety symptoms are linked to new-onset suicidal ideation after six months of follow-up in outpatients with major depressive disorder. J Affect Disord 2015;187:183-187.
29.
Goes FS: The importance of anxiety states in bipolar disorder. Curr Psychiatry Rep 2015;17:3.
30.
CONVERGE Consortium: Sparse whole-genome sequencing identifies two loci for major depressive disorder. Nature 2015;523:588-591.
31.
Nivoli AM, Pacchiarotti I, Rosa AR, Popovic D, Murru A, Valenti M, et al: Gender differences in a cohort study of 604 bipolar patients: the role of predominant polarity. J Affect Disord 2011;133:443-449.
32.
Popovic D, Torrent C, Goikolea JM, Cruz N, Sanchez-Moreno J, Gonzalez-Pinto A, et al: Clinical implications of predominant polarity and the polarity index in bipolar disorder: a naturalistic study. Acta Psychiatr Scand 2014;129:366-374.
33.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4, text revised. Washington, American Psychiatric Association, 2000.
34.
Ramos-Brieva JA, Cordero Villafafila A: Validation of the Castillian version of the Hamilton Rating Scale for Depression (in Spanish). Actas Luso Esp Neurol Psiquiatr Cienc Afines 1986;14:324-334.
35.
Colom F, Vieta E, Daban C, Pacchiarotti I, Sanchez-Moreno J: Clinical and therapeutic implications of predominant polarity in bipolar disorder. J Affect Disord 2006;93:13-17.
36.
Carvalho AF, Quevedo J, McIntyre RS, Soeiro-de-Souza MG, Fountoulakis KN, Berk M, et al: Treatment implications of predominant polarity and the polarity index: a comprehensive review. Int J Neuropsychopharmacol 2014;18:1-11.
37.
Vieta E: Pros and cons of specialised care in bipolar disorder: an international perspective. Br J Psychiatry 2013;202:170-171.
38.
Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I: Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001;125:279-284.
39.
Carafa V, Nebbioso A, Altucci L: Sirtuins and disease: the road ahead. Front Pharmacol 2012;3:4.
40.
Codocedo JF, Allard C, Godoy JA, Varela-Nallar L, Inestrosa NC: SIRT1 regulates dendritic development in hippocampal neurons. PLoS One 2012;7:e47073.
41.
Turecki G, Ernst C, Jollant F, Labonte B, Mechawar N: The neurodevelopmental origins of suicidal behavior. Trends Neurosci 2012;35:14-23.
42.
Kamali M, Saunders EF, Prossin AR, Brucksch CB, Harrington GJ, Langenecker SA, et al: Associations between suicide attempts and elevated bedtime salivary cortisol levels in bipolar disorder. J Affect Disord 2012;136:350-358.
43.
Westrin A, Ekman R, Traskman-Bendz L: Alterations of corticotropin releasing hormone (CRH) and neuropeptide Y (NPY) plasma levels in mood disorder patients with a recent suicide attempt. Eur Neuropsychopharmacol 1999;9:205-211.
44.
Pfennig A, Kunzel HE, Kern N, Ising M, Majer M, Fuchs B, et al: Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression. Biol Psychiatry 2005;57:336-342.
45.
Ota KT, Duman RS: Environmental and pharmacological modulations of cellular plasticity: role in the pathophysiology and treatment of depression. Neurobiol Dis 2013;57:28-37.
46.
Mateus-Pinheiro A, Patricio P, Bessa JM, Sousa N, Pinto L: Cell genesis and dendritic plasticity: a neuroplastic pas de deux in the onset and remission from depression. Mol Psychiatry 2013;18:748-750.
47.
Pandey GN, Dwivedi Y, Rizavi HS, Ren X, Zhang H, Pavuluri MN: Brain-derived neurotrophic factor gene and protein expression in pediatric and adult depressed subjects. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:645-651.
48.
Schmidt HD, Duman RS: Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models. Neuropsychopharmacology 2010;35:2378-2391.
49.
Vieta E: The bipolar maze: a roadmap through translational psychopathology. Acta Psychiatr Scand 2014;129:323-327.
50.
Goldstein TR, Ha W, Axelson DA, Goldstein BI, Liao F, Gill MK, et al: Predictors of prospectively examined suicide attempts among youth with bipolar disorder. Arch Gen Psychiatry 2012;69:1113-1122.
51.
McIntyre RS, Muzina DJ, Kemp DE, Blank D, Woldeyohannes HO, Lofchy J, et al: Bipolar disorder and suicide: research synthesis and clinical translation. Curr Psychiatry Rep 2008;10:66-72.
52.
Chamberlain SR, Odlaug BL, Schreiber LR, Grant JE: Clinical and neurocognitive markers of suicidality in young adults. J Psychiatr Res 2013;47:586-591.
53.
Schumann G, Binder EB, Holte A, de Kloet ER, Oedegaard KJ, Robbins TW, et al: Stratified medicine for mental disorders. Eur Neuropsychopharmacol 2014;24:5-50.
54.
Vieta E: Personalised medicine applied to mental health: precision psychiatry (in Spanish). Rev Psiquiatria Salud Mental 2015;8:117-118.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.